期刊文献+

呼吸道铜绿假单胞菌对氨基糖苷类抗生素药敏试验结果及耐药规律 被引量:3

下载PDF
导出
摘要 目的了解呼吸道铜绿假单胞菌对氨基糖苷类抗生素敏感情况及耐药规律。方法收集并分析361株呼吸道铜绿假单胞菌对氨基糖苷类抗生素药敏资料,并探讨其耐药规律。结果本院呼吸道铜绿假单胞菌对阿米卡星最敏感,敏感率达82.2%。其次为奈替米星,敏感率46.3%。庆大霉素和妥布霉素的耐药率约60%。对4种抗生素同时敏感菌株为115株,占总数的31.9%,同时耐药菌株49株,占13.6%。对阿米卡星敏感而对其它3种抗生素耐药菌株79株,占21.9%。对阿米卡星和奈替米星敏感,而对另两种抗生素耐药菌株为41株,占11.4%。结论阿米卡星在氨基糖苷类抗生素中对铜绿假单胞菌最敏感。铜绿假单胞菌对4种抗生素存在不同程度交叉耐药,妥布霉素与庆大霉素交叉耐药更严重。
机构地区 解放军第 解放军第
出处 《临床肺科杂志》 2009年第6期830-831,共2页 Journal of Clinical Pulmonary Medicine
  • 相关文献

参考文献4

二级参考文献35

共引文献329

同被引文献31

  • 1Mohanty S,Maurya V, Gaind R, et al. Phenotypic characterizationand colistin susceptibilities of cari>apenem - resistant of Pseiidomonasaeruginosa and Acinetobacter spp [ J ]. J Infect Dev Ctries, 2013, 7(11):880-887.
  • 2Tada T,Miyoshi - Akiyama T,Kato Y,et al. Emergence of 16SrRNA methylase - producing Acinetobacter baumannii and Pseiido-monas aeruginosa isolates in hospitals in Vietnam[ J]. BMC InfectDis, 2013,13(1) :251.
  • 3Lfvia CF, Patricia* R, Ketrin CS, et al. Isolation of Pseudomonasaeruginosa Coproducing Metallo - p - Lactamase SPM - 1 and16SrRNA Methylase RmtDl in an Urban River[J]. Antimicrob. A-gents Chemother,2011,55(6) : 3063 -3064.
  • 4Yamane, KF Rossi, MG Barberino,et al. 16S ribosomal RNA meth-ylase rmtD produced by Klebsiella pneumoniae in Brazil[ J]. J Anti-microb Chemother, 2008,61(3) :746 -747.
  • 5Kim JY, Park YJ, Kwon HJ, et al. Occurrence and mechanisms ofamikacin resistance and its association with beta - lactamases inPseudomonas aeruginosa: a Korean nationwide study [ J] . J Antimi-ciob Chemother, 2008,62(3) :479 -483.
  • 6Landman D,Quale J. Pseudomonas aeruginosa Acinetobacter baumannii:pathogens of the millennium[J].Ochsner Clinic Reports on Serious Hospital Infection,2002,(01):1-7.
  • 7Paramythiotou E,Lucet JC,Timsit JF. Acquisition of multidrug-resistant Pseudomonas aeruginosain patients in intensive care units:role of antibiotics with antipseudomonal activity[J].Clinical Infectious Diseases,2004,(02):670-677.
  • 8Aloush V,Navon-Venezia S,Seigman-Igra Y. Multi drug-resistant Pseudomonas aeruginosa:risk factors and clinical impact[J].Antimicrobial Agents and Chemotherapy,2006,(08):43-48.doi:10.1128/AAC.50.1.43-48.2006.
  • 9Perez F,Hujer AM, Hujer KM,et al. Global challenge o{ multi drug-resistant acinetobacter baumannii[J]. Antimi- crob Agents Chemother, 2007,51 (7) : 3471-3484.
  • 10Gomez E, Sanchez M,Gul Z, et al. Polymyxin combination therapy and the use of serum bactericidal titers in the management of KPC-Producing klebsiella pneumoniae in- {ections..a report of 3 cases[J]. Case Rep Med,2011,28 (10) :659769.

引证文献3

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部